|
|
| | N-[(2-Chloro-6-fluorophenyl)methyl]-5-(1H-indazol-3-yl)-3-thiophenecarboxamide Basic information |
| | N-[(2-Chloro-6-fluorophenyl)methyl]-5-(1H-indazol-3-yl)-3-thiophenecarboxamide Chemical Properties |
| Boiling point | 634.8±55.0 °C(Predicted) | | density | 1.444±0.06 g/cm3(Temp: 20 °C; Press: 760 Torr)(Predicted) | | pka | 13.05±0.40(Predicted) | | form | Solid | | color | White to off-white |
| | N-[(2-Chloro-6-fluorophenyl)methyl]-5-(1H-indazol-3-yl)-3-thiophenecarboxamide Usage And Synthesis |
| Uses | XMU-MP-9 is a bifunctional compound that binds to the C2 domain of Nedd4-1 and the allosteric site of K-Ras. XMU-MP-9 enhances the interaction between Nedd4-1 and K-Ras, induces conformational changes in the Nedd4-1/K-Ras complex, promotes the ubiquitination and degradation of multiple K-Ras mutants, and inhibits the proliferation of cells carrying K-Ras mutants. XMU-MP-9 can be used in cancer research[1]. | | References | [1] Taoling Zeng, et al. "Targeting oncogenic K-Ras mutants with a small-molecule degrader through Nedd4-1."bioRxiv(2024): 2024-04. |
| | N-[(2-Chloro-6-fluorophenyl)methyl]-5-(1H-indazol-3-yl)-3-thiophenecarboxamide Preparation Products And Raw materials |
|
|
Tag:N-[(2-Chloro-6-fluorophenyl)methyl]-5-(1H-indazol-3-yl)-3-thiophenecarboxamide(2251130-41-1)
Related Product Information
|
|
3-Thiophenecarboxamide, 5-(6-amino-1H-indazol-3-yl)-N-[(2-chloro-6-fluorophenyl)methyl]-
3-Thiophenecarboxamide, N-[(2-chloro-6-fluorophenyl)methyl]-5-(1H-indazol-3-yl)-, 2,2,2-trifluoroacetate (1:1)
N-[(2-Chloro-6-fluorophenyl)methyl]-5-(1H-indazol-3-yl)-3-thiophenecarboxamide
2-Propen-1-one, 1-[(3S)-4-[(7R)-7-[6-amino-4-methyl-3-(trifluoromethyl)-2-pyridinyl]-6-chloro-8-fluoro-2-[[(2S)-1-methyl-2-pyrrolidinyl]methoxy]-4-quinazolinyl]-3-methyl-1-piperazinyl]-
2,7-Diazaspiro[4.4]nonane-2-acetamide, α-cyclopentyl-7-[[(2R,3R)-3-cyclopropyl-1-methyl-2-aziridinyl]carbonyl]-N-[(1R,10S,12S,18S)-1-[5-(4-cyclopropyl-1-piperazinyl)-2-[(1S)-1-methoxyethyl]-3-pyridinyl]-2,7,8,10,11,12,13,16,17,18,19,21,22,23-tetradecahydro-22,22-dimethyl-13,19-dioxo-2-(2,2,2-trifluoroethyl)-15H-3,5-etheno-14,18-imino-6,10-methano-6H-pyrrolo[3,4-g][1,12,4,18]dioxadiazacyclodocosin-12-yl]-, (αS,5S)-
NAV2729
|